V. Dal Col

发表

Synthesis, pharmacological evaluation, and σ1 receptor interaction analysis of hydroxyethyl substituted piperazines.

E. Laurini, S. Pricl, P. Bednarski, 2014, Journal of medicinal chemistry.

The sigma enigma: in vitro/in silico site-directed mutagenesis studies unveil σ1 receptor ligand binding.

K. Klempnauer, E. Laurini, D. Marson, 2014, Biochemistry.

Pd-catalyzed direct C-H bond functionalization of spirocyclic σ1 ligands: generation of a pharmacophore model and analysis of the reverse binding mode by docking into a 3D homology model of the σ1 receptor.

E. Laurini, S. Pricl, B. Wünsch, 2012, Journal of medicinal chemistry.

Another brick in the wall. Validation of the σ1 receptor 3D model by computer-assisted design, synthesis, and activity of new σ1 ligands.

E. Laurini, D. Marson, M. Fermeglia, 2012, Molecular pharmaceutics.

2-difluoromethylene-4-methylenepentanoic acid, a paradoxical probe able to mimic the signaling role of 2-oxoglutaric acid in cyanobacteria.

E. Laurini, M. Fermeglia, S. Pricl, 2011, Organic letters.

Target sequencing approach intended to discover new mutations in non-syndromic intellectual disability.

P. Bosco, C. Romano, A. Morgan, 2015, Mutation research.

Smoothened (SMO) receptor mutations dictate resistance to vismodegib in basal cell carcinoma

S. Pilotti, E. Laurini, D. Marson, 2015, Molecular oncology.

Tell me something I do not know. Multiscale molecular modeling of dendrimer/ dendron organization and self-assembly in gene therapy.

P Posocco, E Laurini, V Dal Col, 2012, Current medicinal chemistry.